{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:14:02Z","timestamp":1779344042616,"version":"3.51.4"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate the effectiveness of different oral Chinese patent medicines (CPMs) combined with conventional treatment (CT) in the treatment of myocardial infarction with heart failure (MI-HF) using a Bayesian network Meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Computerized searches were conducted in CNKI, WanFang, VIP, SinoMed, PubMed, EMbase, Web of Science, and the Cochrane Library for relevant randomized controlled trials (RCTs) published from database inception until October 15, 2025. The quality of the included studies was assessed using the Cochrane Risk of Bias tool (RoB2). Statistical analysis was performed using Stata 17.0 and RevMan 5.3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 42 RCTs were included, involving 12 oral CPMs, 6 outcome indicators and adverse reactions. In terms of improving the total clinical effective rate, Yixinshu capsules demonstrated the best therapeutic effect. Xintong oral liquid showed the best effect in improving LVEF and reducing LVESD. For reducing LVEDD, Shexiang Baoxin pill was optimal. Guanxin Shutong capsules were the most effective for lowering NT-proBNP and increasing the 6\u2005MWT distance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Oral CPMs combined with CT significantly improve cardiac function, ventricular remodeling, and exercise tolerance in MI-HF. While short-term tolerability is favorable, poor reporting limits definitive safety conclusions. Notably, Xintong Oral Liquid, Guanxin Shutong Capsules, and Qili Qiangxin Capsules exhibit the most outstanding comprehensive benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      , PROSPERO CRD420251234570.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1832017","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:46:37Z","timestamp":1779342397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions"],"prefix":"10.3389","volume":"13","author":[{"given":"Yiying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruikang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Graduate School of Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guancheng","family":"Ye","sequence":"additional","affiliation":[{"name":"Graduate School of Beijing University of Chinese Medicine","place":["Beijing, China"]},{"name":"Department of Rheumatology, Dongzhimen Hospital, Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanchun","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"Graduate School of Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulian","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Endocrinology, Yuquan Hospital, Tsinghua University","place":["Beijing, China"]},{"name":"School of Medicine, Tsinghua University","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"B1","volume-title":"World Heart Report 2023: Confronting the World\u2019s Number One Killer","year":"2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/eurjhf\/hfr072","article-title":"Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction","volume":"13","author":"Hoekstra","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1002\/ehf2.15265","article-title":"Survival after myocardial infarction according to left ventricular function and heart failure symptoms","volume":"12","author":"Jortveit","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jamacardio.2020.0239","article-title":"Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting","volume":"5","author":"Sun","year":"2020","journal-title":"JAMA Cardiol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2470-7511.312595","article-title":"2020 Expert consensus on the prevention and treatment of heart failure after myocardial infarction","volume":"6","year":"2021","journal-title":"Cardiol. Plus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/AGINGADV.AGINGADV-D-24-00025","article-title":"Artificial intelligence in age-related cardiogenic shock prediction: a systematic review and meta-analysis","volume":"2","author":"Popat","year":"2025","journal-title":"Aging Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.19540\/j.cnki.cjcmm.20230724.501","article-title":"Network meta-analysis of efficacy and safety of different traditional Chinese medicine injections in treating acute myocardial infarction complicated with heart failure","volume":"48","author":"Sun","year":"2023","journal-title":"China J Chin Mater Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/AGINGADV.AGINGADV-D-25-00004","article-title":"Current status of research on the role of natural products and their active ingredients in the treatment of cardiovascular aging: a narrative review","volume":"2","author":"Zhang","year":"2025","journal-title":"Aging Adv"},{"key":"B10","first-page":"1030","article-title":"Research progress of traditional Chinese medicine in treating acute myocardial infarction complicated with heart failure","volume":"44","author":"Yang","year":"2022","journal-title":"Hebei J Trad Chin Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.19540\/j.cnki.cjcmm.20231014.501","article-title":"Network meta-analysis of different Chinese patent medicines in treating coronary heart disease complicated with heart failure","volume":"49","author":"Wang","year":"2024","journal-title":"China J Chin Mater Med"},{"key":"B12","first-page":"873","article-title":"Research progress of meta-analysis on Chinese patent medicines in treating acute myocardial infarction","volume":"23","author":"Yuan","year":"2025","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.19540\/j.cnki.cjcmm.20231212.502","article-title":"Evidence map analysis of clinical research on Chinese patent medicines for heart failure after acute myocardial infarction","volume":"49","author":"Zhang","year":"2024","journal-title":"China J Chin Mater Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.19540\/j.cnki.cjcmm.20240523.501","article-title":"Network meta-analysis of oral Chinese patent medicines combined with conventional western medicine in treating gastroesophageal reflux disease","volume":"49","author":"Zhu","year":"2024","journal-title":"China J Chin Mater Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","article-title":"Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the shock academic research consortium (SHARC)","volume":"148","author":"Waksman","year":"2023","journal-title":"Circulation"},{"key":"B17","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"B18","first-page":"720","article-title":"Effect of compound danshen dripping pills on myocardial and vascular endothelial function in patients with acute myocardial infarction complicated with heart failure","volume":"35","author":"Huang","year":"2022","journal-title":"J Mathematical Med"},{"key":"B19","first-page":"1009","article-title":"Efficacy analysis of yixinshu capsules in treating old myocardial infarction complicated with chronic heart failure","volume":"13","author":"Ge","year":"2015","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"B20","first-page":"234","article-title":"Clinical study of compound danshen dripping pills combined with tolvaptan in treating acute myocardial infarction complicated with heart failure","volume":"35","author":"Zhang","year":"2020","journal-title":"Drugs Clin"},{"key":"B21","first-page":"2919","article-title":"Effect of Xuefu zhuyu capsules on cardiac function in patients with heart failure after emergency PCI for acute myocardial infarction","volume":"30","author":"Zhang","year":"2021","journal-title":"Modern J Integr Trad Chin Western Med"},{"key":"B22","first-page":"1150","article-title":"Therapeutic effect of guanxin shutong capsules combined with clopidogrel on patients with acute myocardial infarction complicated with heart failure","volume":"32","author":"Li","year":"2019","journal-title":"J Med Theory Pract"},{"key":"B23","first-page":"124","article-title":"Effect of guanxin shutong capsules combined with clopidogrel on NT-proBNP and cardiac function in patients with acute myocardial infarction complicated with heart failure","volume":"49","author":"Shi","year":"2022","journal-title":"Liaoning J Trad Chin Med"},{"key":"B24","first-page":"44","article-title":"Clinical efficacy of huangqi baoxin granules in treating acute myocardial infarction complicated with heart failure and its effect on Serum myocardial injury factors","volume":"27","author":"Li","year":"2019","journal-title":"Chin Folk Therapies"},{"key":"B25","first-page":"1758","article-title":"Clinical observation of nicorandil tablets combined with qishen yiqi dripping pills in treating heart failure after percutaneous coronary intervention","volume":"39","author":"Dou","year":"2023","journal-title":"J Pract Trad Chin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.14164\/j.cnki.cn11-5581\/r.2024.15.038","article-title":"Clinical study on effect of qishen yiqi dripping pills mediated cardiac fibrosis functional changes on short-term prognosis in patients with heart failure after myocardial infarction","volume":"18","author":"Zhang","year":"2024","journal-title":"Chin J Modern Drug Appl"},{"key":"B27","first-page":"503","article-title":"Clinical observation of qishen yiqi dripping pills in treating 100 cases of chronic heart failure after myocardial infarction","volume":"11","author":"Ren","year":"2017","journal-title":"Dis Surveillance Control"},{"key":"B28","first-page":"51","article-title":"Efficacy observation of shexiang tongxin dripping pills on old myocardial infarction complicated with chronic heart failure","volume":"17","author":"Qiu","year":"2019","journal-title":"Chin J Geri Care"},{"key":"B29","first-page":"1","article-title":"Clinical study on effect of shexiang baoxin pills mediated endothelial function changes on short-term prognosis in patients with heart failure after myocardial infarction","volume":"18","author":"Liao","year":"2024","journal-title":"Chin J Modern Drug Appl"},{"key":"B30","first-page":"67","article-title":"Clinical observation of shexiang baoxin pills combined with conventional therapy in treating elderly myocardial infarction patients complicated with heart failure","volume":"4","author":"Guo","year":"2012","journal-title":"Clin J Chin Med"},{"key":"B31","first-page":"1807","article-title":"Efficacy observation of enhanced external counterpulsation combined with shexiang baoxin pills in treating acute myocardial infarction complicated with left heart failure","volume":"26","author":"Li","year":"2017","journal-title":"Modern J Integr Trad Chin Western Med"},{"key":"B32","first-page":"1","article-title":"Clinical effect of shexiang baoxin pills in treating heart failure after myocardial infarction","volume":"17","author":"Wei","year":"2024","journal-title":"Clin Rational Drug Use"},{"key":"B33","first-page":"15","article-title":"Efficacy observation of enhanced external counterpulsation combined with shexiang baoxin pills in treating acute myocardial infarction complicated with left heart failure","volume":"7","author":"Kong","year":"2015","journal-title":"Clin J Chin Med"},{"key":"B34","first-page":"53","article-title":"Effect of shexiang baoxin pills on cardiac function, oxygen free radical metabolism and inflammatory factors in patients with heart failure after acute myocardial infarction","volume":"21","author":"Liu","year":"2015","journal-title":"Guid J Trad Chin Med Pharmacy"},{"key":"B35","first-page":"60","article-title":"Clinical observation of tongxinluo capsules in treating acute myocardial infarction complicated with left heart dysfunction","volume":"46","author":"Shi","year":"2006","journal-title":"Shandong Med J"},{"key":"B36","first-page":"3374","article-title":"Clinical study of xinnaoshutong capsules combined with bisoprolol in treating myocardial infarction complicated with cardiac dysfunction","volume":"17","author":"Li","year":"2019","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"B37","first-page":"1310","article-title":"Clinical observation of xinnaoshutong capsules in treating 41 cases of myocardial infarction complicated with chronic cardiac dysfunction","volume":"11","author":"Shi","year":"2013","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"B38","first-page":"2201","article-title":"Efficacy observation of Xintong oral liquid combined with enoxaparin sodium in treating heart failure after acute myocardial infarction","volume":"35","author":"He","year":"2022","journal-title":"J Med Theory Pract"},{"key":"B39","first-page":"37","article-title":"Efficacy of xintong oral liquid combined with recombinant human brain natriuretic peptide for injection in treating acute myocardial infarction complicated with heart failure and its effect on cardiac function","volume":"17","author":"Shi","year":"2024","journal-title":"Clin Rational Drug Use"},{"key":"B40","first-page":"9","article-title":"Clinical observation of Xintong oral liquid in treating acute myocardial infarction complicated with heart failure","volume":"24","author":"Xu","year":"2024","journal-title":"Pract Clin J Integr Trad Chin Western Med"},{"key":"B41","first-page":"128","article-title":"Improving effect of Xintong oral liquid on cardiac function in heart failure after acute myocardial infarction (qi deficiency and phlegm-stasis syndrome)","volume":"26","author":"Chen","year":"2020","journal-title":"Chin J Experimental Trad Med Formulae"},{"key":"B42","first-page":"2352","article-title":"Clinical study of xintong oral liquid combined with recombinant human brain natriuretic peptide for injection in treating acute myocardial infarction complicated with heart failure","volume":"35","author":"Yan","year":"2020","journal-title":"Drugs Clin"},{"key":"B43","first-page":"111","article-title":"Clinical efficacy of milrinone combined with qili qiangxin capsules in treating acute myocardial infarction complicated with heart failure","volume":"16","author":"Chen","year":"2021","journal-title":"China Pract Med"},{"key":"B44","first-page":"170","article-title":"Efficacy observation of qili qiangxin capsules in patients with acute myocardial infarction complicated with heart failure undergoing interventional therapy","volume":"10","author":"Zhu","year":"2015","journal-title":"China Pract Med"},{"key":"B45","first-page":"7","article-title":"Qili qiangxin capsules as adjuvant therapy for 53 cases of acute myocardial infarction complicated with heart failure","volume":"12","author":"Pang","year":"2014","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"B46","first-page":"1269","article-title":"Efficacy of qili qiangxin capsules combined with rhBNP in patients with heart failure after acute myocardial infarction","volume":"30","author":"Xu","year":"2024","journal-title":"Int Med Health Guid"},{"key":"B47","first-page":"125","article-title":"Effect of qili qiangxin capsules combined with conventional western medicine on patients with heart failure after myocardial infarction and its effect on cardiac function","volume":"31","author":"Luo","year":"2019","journal-title":"Strait Pharmaceutical J"},{"key":"B48","first-page":"123","article-title":"Efficacy observation of qili qiangxin capsules combined with digoxin in treating heart failure after myocardial infarction","volume":"9","author":"Xi","year":"2011","journal-title":"Guide China Med"},{"key":"B49","first-page":"100","article-title":"Therapeutic effect of qili qiangxin capsules combined with sacubitril\/valsartan on elderly patients with heart failure after acute myocardial infarction","volume":"32","author":"Han","year":"2024","journal-title":"Clin Res"},{"key":"B50","first-page":"80","article-title":"Effect of qili qiangxin capsules combined with sacubitril\/valsartan in treating elderly patients with heart failure after acute myocardial infarction","volume":"34","author":"Xie","year":"2022","journal-title":"Med J Chin People\u2019s Health"},{"key":"B51","first-page":"96","article-title":"Effect of qili qiangxin capsules combined with levosimendan in treating patients with acute myocardial infarction complicated with heart failure","volume":"36","author":"Pan","year":"2024","journal-title":"Med J Chin People\u2019s Health"},{"key":"B52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.16458\/j.cnki.1007-0893.2022.14.021","article-title":"Efficacy analysis of qili qiangxin capsules in treating elderly patients with acute myocardial infarction complicated with heart failure","volume":"32","author":"Dai","year":"2022","journal-title":"Shenzhen J Integr Trad Chin Western Med"},{"key":"B53","first-page":"686","article-title":"Therapeutic effect of qili qiangxin capsules on patients with heart failure after delayed PCI for acute myocardial infarction","volume":"8","author":"Bai","year":"2013","journal-title":"World Chin Med"},{"key":"B54","first-page":"1438","article-title":"Study on effect of qili qiangxin capsules on clinical symptoms and cardiac function in patients with heart failure after myocardial infarction","volume":"27","author":"Qiao","year":"2018","journal-title":"Modern J Integr Trad Chin Western Med"},{"key":"B55","first-page":"785","article-title":"Effect of qili qiangxin capsules as adjuvant therapy on cardiac function, renal function and prognosis in patients with old myocardial infarction complicated with heart failure","volume":"19","author":"Chen","year":"2020","journal-title":"Chin J Difficult Compl Cases"},{"key":"B56","first-page":"493","article-title":"Effect of qili qiangxin capsules combined with milrinone on arterial blood flow and cardiac function in patients with myocardial infarction complicated with heart failure","volume":"41","author":"Song","year":"2020","journal-title":"Shaanxi J Trad Chin Med"},{"key":"B57","first-page":"350","article-title":"Clinical observation of qili qiangxin capsules combined with levosimendan injection in treating elderly patients with acute myocardial infarction complicated with left heart failure","volume":"22","author":"Liu","year":"2023","journal-title":"Chin J Difficult Compl Cases"},{"key":"B58","first-page":"93","article-title":"Efficacy observation of qili qiangxin capsules in treating 32 cases of acute myocardial infarction complicated with heart failure","volume":"32","author":"Fu","year":"2010","journal-title":"Hebei J Trad Chin Med"},{"key":"B59","first-page":"685","article-title":"Clinical value of recombinant human brain natriuretic peptide combined with qili qiangxin capsules in treating elderly patients with acute myocardial infarction complicated with heart failure","volume":"24","author":"Zhang","year":"2022","journal-title":"Chin J Geriatric Heart Brain Vessel Dis"},{"key":"B60","first-page":"1475","article-title":"Experimental study on xintong oral liquid inhibiting excessive mitosis of cardiomyocytes in heart failure rats by regulating Pink1\/parkin signaling pathway activity","volume":"45","author":"Zhang","year":"2022","journal-title":"J Chin Med Mater"},{"key":"B61","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11655-022-2891-6","article-title":"Shexiang baoxin pill regulates intimal hyperplasia, migration, and apoptosis after platelet-derived growth factor-BB-stimulation of vascular smooth muscle cells via miR-451","volume":"28","author":"Li","year":"2022","journal-title":"Chin J Integr Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"115186","DOI":"10.1016\/j.biopha.2023.115186","article-title":"Shexiang baoxin pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling","volume":"165","author":"Wei","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B63","doi-asserted-by":"publisher","first-page":"700630","DOI":"10.3389\/fcvm.2021.700630","article-title":"Shexiang baoxin pills inhibited proliferation and migration of human coronary artery smooth muscle cells via PI3K\/AKT\/mTOR pathway","volume":"8","author":"Hua","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B64","first-page":"226","article-title":"Study on protective mechanism of guanxin shutong capsules and its individual medicines on cardiomyocyte and aortic smooth muscle cell injury","volume":"19","author":"Huang","year":"2013","journal-title":"Chin J Exp Trad Med Formulae"},{"key":"B65","doi-asserted-by":"publisher","first-page":"118821","DOI":"10.1016\/j.jep.2024.118821","article-title":"Traditional Chinese medication qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the phosphoinositide 3-kinase\/protein kinase B\/forkhead box O3 axis","volume":"337","author":"Wu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1248\/bpb.b19-00050","article-title":"Qiliqiangxin attenuates oxidative stress-induced mitochondrion-dependent apoptosis in cardiomyocytes via PI3K\/AKT\/GSK3\u03b2 signaling pathway","volume":"42","author":"Zhao","year":"2019","journal-title":"Biol Pharm Bull"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0310897","DOI":"10.1371\/journal.pone.0310897","article-title":"Qili qiangxin capsule attenuates myocardial fibrosis by modulating collagen homeostasis post-infarction in rats","volume":"19","author":"Sun","year":"2024","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"8374","DOI":"10.1038\/srep08374","article-title":"Traditional Chinese medication qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice","volume":"5","author":"Tao","year":"2015","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11655-024-3654-3","article-title":"Mechanism of qili qiangxin capsule for heart failure based on miR133a-endoplasmic Reticulum stress","volume":"30","author":"Ji","year":"2024","journal-title":"Chin J Integr Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"112227","DOI":"10.1016\/j.jep.2019.112227","article-title":"A network pharmacology approach to discover action mechanisms of yangxinshi tablet for improving energy metabolism in chronic ischemic heart failure","volume":"246","author":"Wu","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e98047","DOI":"10.1371\/journal.pone.0098047","article-title":"Tongxinluo protects against pressure overload-induced heart failure in mice involving VEGF\/Akt\/eNOS pathway activation","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"B72","doi-asserted-by":"publisher","first-page":"981206","DOI":"10.3389\/fphar.2022.981206","article-title":"Qishenyiqi dripping pill protects against myocardial ischemia\/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology","volume":"13","author":"Li","year":"2022","journal-title":"Front Pharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/mgr.MEDGASRES-D-23-00013","article-title":"Oxygen-ozone therapy for myocardial ischemic stroke and cardiovascular disorders","volume":"15","author":"Pandolfi","year":"2025","journal-title":"Med Gas Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jrsm.57","article-title":"Using network meta-analysis to evaluate the existence of small-study effects in a network of interventions","volume":"3","author":"Chaimani","year":"2012","journal-title":"Res Synth Methods"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1832017\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T05:46:48Z","timestamp":1779342408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1832017\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":74,"alternative-id":["10.3389\/fcvm.2026.1832017"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1832017","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"article-number":"1832017"}}